HomepageEarnings Events Newsdesk 4 hours ago GE Healthcare (GE) GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents GE Healthcare (NYSE: GE) FY 2026 Other Release APi Group Corporation (APG) APi Group to Acquire Onyx-Fire Protection Services Inc. » « TransUnion (TRU) New TransUnion Digital Business Profile Gives Small Businesses a Simple, Cost-Effective Way to Connect with Customers Newsdesk:
